IP Verse

Curevac Se opposition analysis

COMPANY ANALYSIS

Latest patents of Curevac Se opposed by its competitors

Patent:
EP4023755
Grant Date:
Apr 26, 2023
Title:
Artificial Nucleic Acid Molecules For Improved Protein Expression
Oppositions:
4
Patent:
EP3708668
Grant Date:
Jul 27, 2022
Title:
Artificial Nucleic Acid Molecules For Improved Protein Expression
Oppositions:
4
Patent:
EP3115064
Grant Date:
Nov 24, 2021
Title:
Rna-Coded Antibody
Oppositions:
1
Patent:
EP3297682
Grant Date:
Jul 14, 2021
Title:
Dry Powder Composition Comprising Long-Chain Rna
Oppositions:
2
Patent:
EP3298142
Grant Date:
Jul 14, 2021
Title:
Dry Powder Composition Comprising Long-Chain Rna
Oppositions:
2
Patent:
EP3294326
Grant Date:
Apr 21, 2021
Title:
Prime-Boost Regimens Involving Administration Of At Least One Mrna Construct
Oppositions:
1
Patent:
EP3062798
Grant Date:
May 6, 2020
Title:
Modified Rna With Decreased Immunostimulatory Properties
Oppositions:
2
Patent:
EP3116535
Grant Date:
Aug 7, 2019
Title:
Combination Of Vaccination And Ox40 Agonists
Oppositions:
1
Patent:
EP3173092
Grant Date:
Jun 26, 2019
Title:
Rna Containing Composition For Treatment Of Tumor Diseases
Oppositions:
5
Patent:
EP3326641
Grant Date:
Jun 26, 2019
Title:
Rna Containing Composition For Treatment Of Tumor Diseases
Oppositions:
4

Competitors of Curevac Se

BIONTECH SE

SANOFI

ETHERNA IMMUNOTHERAPIES NV

Want to track Curevac Se?

Feel free to send us a message here and we will get back to you